{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T20:40:56Z","timestamp":1770324056290,"version":"3.49.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Pathology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.carpath.2013.01.005","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T23:46:53Z","timestamp":1362786413000},"page":"357-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A study of prevention and regression of cardiac hypertrophy with a prolactin inhibitor in a biological model of ventricular hypertrophy caused by aorto caval fistulae in rat"],"prefix":"10.1016","volume":"22","author":[{"given":"Juan M.","family":"V\u00e9lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germ\u00e1n A.","family":"Chamorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia C.","family":"Calzada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Zu\u00f1iga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan J.","family":"V\u00e9lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Ochar\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.carpath.2013.01.005_bb0005","first-page":"421","article-title":"Hypertrophy of the left ventricle-etiopathogenesis, clinical consequences and prognosis","volume":"45","author":"Ghanem Wisam","year":"1999","journal-title":"Vnitr Lek"},{"key":"10.1016\/j.carpath.2013.01.005_bb0010","doi-asserted-by":"crossref","first-page":"194S","DOI":"10.1016\/S0895-7061(01)02088-X","article-title":"Fibrosis and ischemia: the real risks in hypertensive heart disease","volume":"14","author":"Frohlich","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.carpath.2013.01.005_bb0015","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/cvr\/cvn022","article-title":"Hypertension and microvascular remodeling","volume":"78","author":"Feihl","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carpath.2013.01.005_bb0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.CIR.86.1.38","article-title":"Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy","volume":"86","author":"Rakusan","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2013.01.005_bb0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.HYP.21.4.391","article-title":"Small artery structure in hypertension: dual processes of remodeling and growth","volume":"21","author":"Heagerty","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.carpath.2013.01.005_bb0030","first-page":"505","article-title":"Vascular remodeling","volume":"28","author":"Mulvany","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.carpath.2013.01.005_bb0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s004280050098","article-title":"Structural analysis of arteriolar and myocardial remodeling in the subendocardial region of patients with hypertensive heart disease and hypertrophic cardiomyopathy","volume":"431","author":"Mundhenke","year":"1997","journal-title":"Virchows Arch"},{"key":"10.1016\/j.carpath.2013.01.005_bb0040","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1161\/01.CIR.0000120390.68287.BB","article-title":"Hypertrophy of the heart. A new therapeutic target?","volume":"109","author":"Frey","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.carpath.2013.01.005_bb0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1157\/13087900","article-title":"Hipertrofia cardiaca: eventos moleculares y celulares","volume":"59","author":"Carre\u00f1o","year":"2006","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0050","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1161\/01.CIR.98.19.1987","article-title":"Regression of left ventricular hypertrophy in patients with hypertension. Blockade of the renin-angiotensin-aldosterone system","volume":"98","author":"Pitt","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2013.01.005_bb0055","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.carpath.2013.01.005_bb0060","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/01.RES.79.4.887","article-title":"Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes","volume":"79","author":"Kijiyama","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2013.01.005_bb0065","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/01.RES.72.6.1245","article-title":"Angiotensin II is mitogenic in neonatal rat cardiac fibroblast","volume":"72","author":"Schorb","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2013.01.005_bb0070","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/01.RES.78.5.829","article-title":"Passive load and angiotensin II evoke differential responses of gene expression and protein synthesis in cardiomyocytes","volume":"78","author":"Kent","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2013.01.005_bb0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/1054-8807(93)90003-K","article-title":"Molecular and cellular mechanisms of induction and regression of cardiac fibrosis in various models of myocardial hypertrophy","volume":"2","author":"Eghbali","year":"1993","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0080","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0022-2828(88)90597-4","article-title":"Structural vs. contractile protein remodeling and myocardial stiffness in hypertrophied rat left ventricle","volume":"20","author":"Jalil","year":"1988","journal-title":"J Mol Cell Cardiol"},{"issue":"49","key":"10.1016\/j.carpath.2013.01.005_bb0085","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1161\/CIRCULATIONAHA.108.826214","article-title":"Effect of the direct renin inhibitor aliskiren, the angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy","volume":"119","author":"Solomon","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.carpath.2013.01.005_bb0090","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00005344-200403000-00008","article-title":"Angiotensin receptor antagonist regresses left ventricular hypertrophy associated with diabetic nephropathy in dialysis patients","volume":"43","author":"Kanno","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"10.1016\/j.carpath.2013.01.005_bb0095","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1526-0968.2004.00142.x","article-title":"Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy","volume":"8","author":"Suzuki","year":"2004","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.carpath.2013.01.005_bb0100","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/00004872-199510000-00008","article-title":"A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries","volume":"13","author":"Shaw","year":"1995","journal-title":"J Hypertens"},{"key":"10.1016\/j.carpath.2013.01.005_bb0105","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.HYP.32.2.305","article-title":"Effects of losartan and enalapril on small artery structure in hypertensive rats","volume":"32","author":"Rizzoni","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.carpath.2013.01.005_bb0110","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.carpath.2013.01.005_bb0115","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/edrv.19.3.0334","article-title":"Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice","volume":"19","author":"Bole-Feysot","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.carpath.2013.01.005_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1018708704335","article-title":"Prolactin and mammary gland development","volume":"4","author":"Horseman","year":"1999","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"1","key":"10.1016\/j.carpath.2013.01.005_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2007-0017","article-title":"What can we learn from rodents about prolactin in humans?","volume":"29","author":"Ben-Jonathan","year":"2008","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.carpath.2013.01.005_bb0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/REP-06-0299","article-title":"Reproductive role of prolactin","volume":"133","author":"Bachelot","year":"2007","journal-title":"Reproduction"},{"key":"10.1016\/j.carpath.2013.01.005_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.physiol.64.081501.131049","article-title":"Prolactin: the new biology and old hormone","volume":"64","author":"Goffin","year":"2002","journal-title":"Ann Rev Physiol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0140","unstructured":"CS Nicoll. Handbook of Physiology, eds. Knobil, E. & Sawyer, WH. (Am Physiol Soc., Bethesda, MD), Vol. 2 pp:253\u2013292."},{"key":"10.1016\/j.carpath.2013.01.005_bb0145","first-page":"1333","volume":"17","author":"Ruers","year":"1985","journal-title":"Transplant Proc"},{"key":"10.1016\/j.carpath.2013.01.005_bb0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0165-6147(89)90106-5","article-title":"New aspects of prolactin and immunity: a lymphocyte derived prolactin-like product and nuclear protein kinase C activation","volume":"10","author":"Russell","year":"1989","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.carpath.2013.01.005_bb0155","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0303-7207(90)90165-5","article-title":"Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells","volume":"68","author":"Yu-Lee","year":"1990","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0160","first-page":"247","article-title":"Prolactin isohormones and fertility","volume":"7","author":"Larrea","year":"1991"},{"key":"10.1016\/j.carpath.2013.01.005_bb0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1677\/erc.1.01076","article-title":"A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone","volume":"13","author":"Ueda","year":"2006","journal-title":"Endocr Related Cancer"},{"key":"10.1016\/j.carpath.2013.01.005_bb0170","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1463-1326.2006.00671.x","article-title":"Adipocyte prolactin: regulation or release and putative functions","volume":"9","author":"Brandebourg","year":"2007","journal-title":"Diabetes, Obesity and Metabolism"},{"issue":"4","key":"10.1016\/j.carpath.2013.01.005_bb0175","first-page":"369","article-title":"Gonadal steroids and immunity","volume":"17","author":"Olsen","year":"1996","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.carpath.2013.01.005_bb0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-4731(90)90270-3","article-title":"Effects of gender and sex steroids on the immune response","volume":"35","author":"Schuurs","year":"1990","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.carpath.2013.01.005_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbrc.2006.03.168","article-title":"Induction of prolactin expression and release in human preadipocytes by cAMP activating ligands","volume":"344","author":"McFarland-Mancini","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.carpath.2013.01.005_bb0190","doi-asserted-by":"crossref","first-page":"8649","DOI":"10.1073\/pnas.85.22.8649","article-title":"Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen","volume":"85","author":"Buckley","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.carpath.2013.01.005_bb0195","first-page":"973","article-title":"Evidence of a rapid stimulation of tyrosine kinase activity by prolactin in Nb2 rat lymphoma","volume":"131","author":"Rillema","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.carpath.2013.01.005_bb0200","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0006-291X(05)80235-9","article-title":"Prolactin stimulation of protein kinase C activity in the rat hypothalamus","volume":"176","author":"De Vito","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.carpath.2013.01.005_bb0205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0303-7207(92)90102-C","article-title":"Prolactin-induced protein kinase C activity in a mouse mammary cell line","volume":"90","author":"Barnejee","year":"1992","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1016\/j.carpath.2013.01.005_bb0215","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0015-0282(16)59768-4","article-title":"Transient hyperprolactinemia during cycle stimulation: influence on the endocrine response and fertilization rate of human oocytes and effects of Bromocriptine treatment","volume":"49","author":"Reinthaller","year":"1988","journal-title":"Fertil Steril"},{"key":"10.1016\/j.carpath.2013.01.005_bb0220","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003495-198836010-00005","article-title":"Therapeutic applications of bromocriptine in endocrine and neurological diseases","volume":"36","author":"Ho","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.carpath.2013.01.005_bb0225","first-page":"74","article-title":"Hyperprolactinemia","volume":"44","author":"Biller","year":"1999","journal-title":"Int J Fertil Women's Med"},{"key":"10.1016\/j.carpath.2013.01.005_bb0230","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1093\/humrep\/del093","article-title":"Metoclopramide-induced hyperprolactinemia caused marked decline in pinopodes and pregnancy rates in mice","volume":"21","author":"Panzan","year":"2006","journal-title":"Hum Reprod"},{"issue":"24","key":"10.1016\/j.carpath.2013.01.005_bb0235","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jacc.2007.10.006","article-title":"Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine","volume":"50","author":"Hilfiker-Kleiner","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.carpath.2013.01.005_bb0240","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.carpath.2013.01.005_bb0245","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ejheart.2008.07.005","article-title":"reversal of IFN-\u03b3, oxLDL and prolactin serum levels correlate with clinical improvement in patients with per partum cardiomyopathy","volume":"10","author":"Forster","year":"2008","journal-title":"European Journal of Heart Failure"},{"key":"10.1016\/j.carpath.2013.01.005_bb0250","first-page":"122","article-title":"Bromocriptine induces regression of left ventricular hypertrophy in peritoneal dialysis patients","volume":"48","author":"Mejia-Rodriguez","year":"2005","journal-title":"Proc West Pharmacol Soc"},{"issue":"2","key":"10.1016\/j.carpath.2013.01.005_bb0255","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1590\/S0066-782X2000000200001","article-title":"Reduction on left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan","volume":"74","author":"Avanza","year":"2000","journal-title":"Arq Bras Cardiol"},{"issue":"1","key":"10.1016\/j.carpath.2013.01.005_bb0260","first-page":"449","article-title":"Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension","volume":"8","author":"Smith","year":"1986","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 6","key":"10.1016\/j.carpath.2013.01.005_bb0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005344-198700106-00006","article-title":"Physiologic versus pathologic hypertrophy and the pressure-overload myocardium","volume":"10","author":"Weber","year":"1987","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0270","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-2828(08)80013-2","article-title":"Molecular mechanism of cardiac cellular hypertrophy by mechanical stress","volume":"27","author":"Yamazaki","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0275","first-page":"H1861","article-title":"Cardiac hypertrophy-induced changes in mRNA levels of TGF-beta, fibronectin and collagen","volume":"262","author":"Villarreal","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0280","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.83.2.504","article-title":"Impairment of the myocardial ultra-structure and changes of cytoskeleton in dilated cardiomyopathy","volume":"83","author":"Schaper","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2013.01.005_bb0285","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.8097594","article-title":"Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium","volume":"260","author":"Tsutsui","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.carpath.2013.01.005_bb0290","doi-asserted-by":"crossref","first-page":"10551","DOI":"10.1016\/S0021-9258(19)50052-7","article-title":"Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy","volume":"267","author":"Sadoshima","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.carpath.2013.01.005_bb0295","first-page":"57","article-title":"Wall stress and patterns of hypertrophy in the human left ventricle","volume":"56","author":"Grossman","year":"1975","journal-title":"Lab Clin Invest"},{"key":"10.1016\/j.carpath.2013.01.005_bb0300","series-title":"Adaptation and desadaptation","article-title":"The failing heart","author":"Meerson","year":"1983"},{"issue":"Suppl 3a","key":"10.1016\/j.carpath.2013.01.005_bb0305","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0002-9343(83)90111-0","article-title":"Prevalence and natural history of electrocardiographic left ventricular hypertrophy","volume":"75","author":"Kannel","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.carpath.2013.01.005_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.76.1.1","article-title":"Angiotensin II and other hypertrophic stimuli mediated by G protein-coupled receptors activate tyrosine kinase, mitogen-activated protein kinase and 90-kD s6 kinase in cardiac myocytes. \u201cThe critical role of Ca\u201d dependent signaling","volume":"76","author":"Sadoshima","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2013.01.005_bb0315","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1161\/01.HYP.23.1.83","article-title":"Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension","volume":"23","author":"Schiffrin","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.carpath.2013.01.005_bb0320","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1161\/01.CIR.101.14.1653","article-title":"Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan","volume":"101","author":"Schiffrin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2013.01.005_bb0325","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF02220609","article-title":"Bromocriptine lessens the incidence of mortality in L-dopa-treated Parkinson's patients: PRADO study discontinued","volume":"43","author":"Przuntek","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0330","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0002-8703(83)90446-5","article-title":"The effects of bromocriptine in patients with congestive heart failure","volume":"106","author":"Francis","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/j.carpath.2013.01.005_bb0335","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cvr\/15.3.175","article-title":"Reduction in vulnerability to ventricular fibrillation by bromocriptine, a dopamine agonist, a dopamine agonist","volume":"15","author":"Falk","year":"1981","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.carpath.2013.01.005_bb0340","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1253\/jcj.56.943","article-title":"Role of sympathetic nerve inhibition in the vasodepressor effect of bromocriptine in normotensive and hypertensive rats","volume":"56","author":"Oguro","year":"1992","journal-title":"Jpn Circ J"},{"issue":"Supp 5","key":"10.1016\/j.carpath.2013.01.005_bb0345","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00005344-198900145-00005","article-title":"The role of dopamine receptors in the treatment of congestive heart failure","author":"Goldberg","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0350","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000122891","article-title":"Effects of bromocriptine on plasma catecholamines in normal men","volume":"28","author":"Van Loon","year":"1979","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.carpath.2013.01.005_bb0355","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/BF03348451","article-title":"Altered dopaminergic modulation of sympathetic nervous system activity in idiopathic edema","volume":"5","author":"Catania","year":"1984","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.carpath.2013.01.005_bb0360","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00005344-198511000-00005","article-title":"Catecholamine, renin aldosterone and arginine vasopressin responses to lower body negative pressure and tilt in normal humans: effects of bromocriptine","volume":"7","author":"Mohanty","year":"1985","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0365","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/jcem-59-1-74","article-title":"Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release","volume":"59","author":"Mannelli","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.carpath.2013.01.005_bb0370","series-title":"New Aspects of the Role of Adrenoceptors in the Cardiovascular System","first-page":"43","article-title":"In vivo operation of prejunctional adrenoceptors in the peripheral sympathetic nervous system","author":"Starke","year":"1986"},{"key":"10.1016\/j.carpath.2013.01.005_bb0375","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.HYP.25.5.1075","article-title":"Effects of bromocriptine on cardiovascular regulation in healthy humans","volume":"25","author":"Schobel","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.carpath.2013.01.005_bb0380","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/cpt1979252137","article-title":"Bromocriptine inhibits norepinephrine release","volume":"25","author":"Ziegler","year":"1979","journal-title":"Clin Pharmacol There"},{"key":"10.1016\/j.carpath.2013.01.005_bb0385","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/jcem-56-3-595","article-title":"Suppression of basal and stimulated noradrenergic activities by the dopamine agonist bromocriptine in man","volume":"56","author":"Carrey","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.carpath.2013.01.005_bb0390","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0304-3940(91)90903-7","article-title":"Dopaminergic regulation of pre-pro NPY mRNA levels in the rat arcuate nucleus","volume":"127","author":"Pelletier","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.carpath.2013.01.005_bb0395","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1006\/jmcc.1999.0934","article-title":"Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes","volume":"31","author":"Lijnen","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0400","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad and, the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.carpath.2013.01.005_bb0405","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1161\/01.CIR.92.8.2306","article-title":"The cellular basis of pacing-induced dilated cardiomyopathy. Myocyte cell loss and myocyte cellular reactive hypertrophy","volume":"92","author":"Kajsutra","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2013.01.005_bb0410","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carpath.2013.01.005_bb0415","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","article-title":"Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis","volume":"33","author":"Robert","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.carpath.2013.01.005_bb0420","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1291\/hypres.27.781","article-title":"Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralcorticoid receptor antagonist","volume":"27","author":"Takeda","year":"2004","journal-title":"Hypertension Res"},{"key":"10.1016\/j.carpath.2013.01.005_bb0425","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/01.RES.0000037091.64492.69","article-title":"Ischemic protection and myofibrillar cardiomyopathy: dose-dependent effects of in vivo delta PKC inhibition","volume":"91","author":"Hahn","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2013.01.005_bb0430","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1161\/01.CIR.0000101682.24138.36","article-title":"Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo","volume":"108","author":"Inagaki","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.carpath.2013.01.005_bb0435","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/01.RES.86.11.1173","article-title":"Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKC epsilon translocation","volume":"86","author":"Mochly-Rosen","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.carpath.2013.01.005_bb0440","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1172\/JCI119755","article-title":"Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates","volume":"100","author":"Bowman","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.carpath.2013.01.005_bb0445","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/415206a","article-title":"Seven-transmembrane-spanning receptors and heart function","volume":"415","author":"Rockman","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.carpath.2013.01.005_bb0450","doi-asserted-by":"crossref","first-page":"S409","DOI":"10.1054\/jcaf.2002.129283","article-title":"Cardiac hypertrophy: role of g protein-coupled receptors","volume":"8","author":"Esposito","year":"2002","journal-title":"J Card Fail"},{"key":"10.1016\/j.carpath.2013.01.005_bb0455","doi-asserted-by":"crossref","first-page":"10140","DOI":"10.1073\/pnas.95.17.10140","article-title":"Enhanced G alpha q signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure","volume":"95","author":"Adams","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.carpath.2013.01.005_bb0460","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.physiol.62.1.237","article-title":"Functional consequences of altering myocardial adrenergic receptor signaling","volume":"62","author":"Koch","year":"2000","journal-title":"Annu Rev Physiol"}],"container-title":["Cardiovascular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880713000185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054880713000185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:27:17Z","timestamp":1762360037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054880713000185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1054880713000185"],"URL":"https:\/\/doi.org\/10.1016\/j.carpath.2013.01.005","relation":{},"ISSN":["1054-8807"],"issn-type":[{"value":"1054-8807","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study of prevention and regression of cardiac hypertrophy with a prolactin inhibitor in a biological model of ventricular hypertrophy caused by aorto caval fistulae in rat","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carpath.2013.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}